Bal Pharma Limited has issued a Postal Ballot Notice to its shareholders seeking approval for the appointment of Dr. Mukesh Beekamchand as a Non-Executive Independent Director. The notice details the process for remote e-voting, which will commence on January 9, 2026, at 9:00 AM IST and conclude on February 7, 2026, at 5:00 PM IST. The results of the postal ballot are expected to be announced on or before February 10, 2026.

Dr. Mukesh Beekamchand, an accomplished doctor with over 25 years of experience in oncology and diabetic care, was initially appointed as an Additional Director on November 12, 2025. His appointment as a Non-Executive Independent Director is for a period of five consecutive years, until February 6, 2031. He has declared that he meets the criteria for independence as required by the Companies Act, 2013, and SEBI Listing Regulations. He does not hold any shares in the company and is not related to any other directors. He has also been appointed as a member of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, effective November 29, 2025.

Shareholders are requested to cast their votes electronically through the NSDL e-voting system. Detailed instructions for e-voting are provided in the notice. The cut-off date for determining voting rights is January 8, 2026. The company has engaged NSDL for facilitating the remote e-voting process.